Interfacial supramolecular interactions regulated oligomer networking into robust sub-nanochannels for efficient osmotic energy conversion
Energy & Environmental Science · 2025 · 18 (18) · 8515-8526
DOI: 10.1039/d5ee03350k ↗Kurz gefasst
Fachartikel in der Zeitschrift Energy & Environmental Science, 2025. Verfasst von Gang Lu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
We engineer a 5-nm sulfonated membrane via oligomer assembly, achieving fast and selective ion transport. This exceptional performance stems from sub-Debye-length nanoconfinement (0.6 nm), charge-directed transport, and ultrashort pathways (5 nm).
Förderung
- National Natural Science Foundation of China
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Lu, G., A, H., Xu, H., Zhao, Y., Zhao, Y., Zhang, H., Dewil, R., Bruggen, B. V. D., & Zheng, S. (2025). Interfacial supramolecular interactions regulated oligomer networking into robust sub-nanochannels for efficient osmotic energy conversion. Energy & Environmental Science, 18(18), 8515-8526. https://doi.org/10.1039/d5ee03350k
Vancouver
Lu G, A H, Xu H, Zhao Y, Zhao Y, Zhang H, et al. Interfacial supramolecular interactions regulated oligomer networking into robust sub-nanochannels for efficient osmotic energy conversion. Energy & Environmental Science. 2025;18(18):8515-8526. doi:10.1039/d5ee03350k
BibTeX
@article{Lu2025,
author = {Lu, Gang and A, Hubao and Xu, Hengyue and Zhao, Yan and Zhao, Yuanyuan and Zhang, Huacheng and Dewil, Raf and Bruggen, Bart Van der and Zheng, Shuang},
title = {Interfacial supramolecular interactions regulated oligomer networking into robust sub-nanochannels for efficient osmotic energy conversion},
journal = {Energy & Environmental Science},
year = {2025},
volume = {18},
number = {18},
pages = {8515--8526},
doi = {10.1039/d5ee03350k}
}
EUVIMED